Investor Information

 

Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the 

  • TSX Venture Exchange (TLT-TSVX) and the
  • OTCQB (TLTFF)

Data last updated on March 14, 2019


 

Number of common shares outstanding

Basic: 144,132,042

Warrants: 36,690,004

Options: 5,835,000

Fully Diluted: 186,657,046

Insider Ownership: 7.4% (8.7% fully diluted)

[stockdio-historical-chart]

Financial Filings

 
Downloaded 200 times.
Downloaded 169 times.
Downloaded 85 times.
Downloaded 53 times.
Downloaded 8 times.
Downloaded 8 times.
Downloaded 7 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 1 times.
 
SEDAR Filings (System for Electronic Document Analysis and Retrieval)

Theralase's complete public securities documents are available in English and French on SEDAR.